VNDA
Vanda Pharmaceuticals Inc.5.36post+$0.03 (+0.56%)at close +$0.10 (+1.91%)
as of 22:52:38 UTCnext report Nov 4 · 91d
Earnings Room‹ back to VNDA
The report
fiscal Q3 2026 · from the company's noticeNov 4after close91days out
Expected movement
market-implied · at the Aug 4 close±30.9%is what the chain prices between now and the expiry below. Not a view we hold.
That span is 136days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.
expiry Dec 18 · first after the reportATM strike 5straddle 1.95ATM IV 78%× 0.85 straddle-to-rangespot 5.36
Blast radius
3 linked · N-PORT + EDGARIf VNDA moves ±30.9% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.
Positioning
3 expiries · as of the Aug 4 closeContracts already committed, not just traded today — puts against calls, sized by expiry. The tick is today's volume moving against that stance; the arrow, how much built up since the prior session.
OI ΔPutsOI
ExpiryOICallsOI Δ
▲ +1%179
Aug 21
17d
2.8k▲ +1%
▲ +0%
287
Sep 18
45d
1.7k▲ +1%
▲ +0%
929
Dec 18
136d
5.4k▲ +0%
The record
expected in pale · actual in full color4/8reports moved further than the options market had pricedtypically ±9.5% realized vs ±10.1% priced
May 6 '26±13.3%→−14.1%×1.06
Feb 11 '26±11.0%→−17.6%×1.60
Oct 29 '25±14.4%→−20.1%×1.40
Jul 31 '25±8.5%→−8.8%×1.03
May 7 '25±10.1%→−3.6%×0.36
Feb 13 '25±8.5%→−6.0%×0.70
Nov 6 '24±6.4%→+2.7%×0.42
Jul 31 '24±8.9%→−3.4%×0.38
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported -0.82 · rev $52M
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.